Experts say that with the market experiencing volatility, investors should look beyond mega-caps like Meta, Amazon and Netflix to find stocks with high earnings growth potential.
Investor’s Business Daily reports that several companies under the radar are expected to report explosive earnings gains over the next year, making them an attractive choice for those looking to grow their portfolios.
Five stocks that can boost your portfolio include:
Privia Health (PRVA) set for triple-digit growth
FactSet predicts that Privia Health, a provider of medical technologies solutions, will see its earnings per shares soar by 125% next year. A further 42% growth is expected the following year.
The company’s 2025 outlook was reassuring to investors despite the challenges in the Medicare Advantage Market.
Privia Health’s stock has risen by 28% since 2025. This is a significant outperformance of the broader US Market, which is down approximately 1%.
Corcept Therapeutics (CORT), a biotech company, rides the biotech wave
Another notable biotech company is Corcept Therapeutics, a firm that focuses on cortisol modulating drugs.
Analysts predict that earnings per share will increase by 55% in 2025, and then another 86% in 2020.
Sales are expected jump by 34% over the next two-year period.
Corcept’s optimistic 2025 forecast was released on February 26th, despite the fact that it missed Q4 estimates.
The stock has gained nearly 20% in the last year.
TG Therapeutics delivers a stunning turnaround
TG Therapeutics’ (TGTX) flagship drug Briumvi has become a major player on the market for multiple sclerosis treatments.
The company, recently profitable, is expected to see a staggering 580% increase in earnings per share by 2025, mainly due to a projected 70% rise in sales.
Shares soared 17% Monday following a strong Q4 results report. TGTX has gained 16.5% in the past year.
TKO Group (TKO) flexes entertainment dominance
TKO Group (TKO), owner of Ultimate Fighting Championships (UFC) & World Wrestling Entertainments (WWE), is set for a dramatic increase in earnings.
Analysts expect earnings per share to increase to $3.04 by 2025, from just two cents a share in 2024. This will be followed by a 73% increase in the following year. Sales are expected to grow by 15.5% next year.
The company reported a strong Q4 result, swinging towards a profit in 2024. TKO stock has risen 4% so far this year.
Gilead Sciences (GILD), a strong forecast, is expected to rebound.
Gilead Sciences, a leading biopharmaceutical firm, is on course to reverse three consecutive earnings declines.
Gilead’s projected earnings per share will increase by 72% in 2025. This is due to the strong sales of its HIV therapy Biktarvy, and its Covid treatment Veklury. An additional 5.5% in 2026.
The stock price has risen by 25% in the last year.
This post Privia, Corcept, and three other low-key stocks with high growth potential to invest in by 2025 could be modified as new information becomes available.
This site is for entertainment only. Click here to read more
